Oren Milstein

Israel Space Agency (ISA)CEO, Stemrad, Principle Investigator

Dr. Oren Milstein is CEO and Chief Scientific Officer of StemRad, an Israeli-American company that develops, manufactures and sells personal protective equipment (PPE) for ionizing radiation. It is the world's only company producing PPE intended to protect users from high energy ionizing radiation and the first to employ selective shielding in its products. Dr. Milstein co-founded StemRad in November of 2011, shortly after the Fukushima Daiichi nuclear disaster in Japan. Formerly, Dr. Milstein was an EMBO fellow at NYU’s Skirball Institute of Biomolecular Medicine, where his research provided basic insights into the mechanism of T cell activation. Later in his career, as an NIH fellow at the Scripps Research Institute, he discovered a novel mechanism for iron deficiency anemia. Subsequently, Oren focused his research on radiation-induced autoimmune hemolytic anemia. Dr. Milstein received his Ph.D. degree from The Weizmann Institute of Science in 2008, where he developed novel strategies for successful bone marrow transplantation into irradiated subjects. He received his B.Sc., Magna Cum Laude, from The Hebrew University in Jerusalem. His research has resulted in several peer-reviewed publications and patents.


International Astronautical Congress 2022

18-22 September 2022

Paris, France


International Astronautical Congress 2021

25-29 October 2021

Dubai, United Arab Emirates


International Astronautical Congress 2020

12-14 October 2020

Cyberspace edition